References-Theoretical Essay G

1. Todd JA, Wicker LS: Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15: 387-395, 2001.
2. Serreze DV, Leiter EH: Genes and pathways underlying autoimmune diabetes in NOD mice. In: Molecular Pathology of Insulin Dependent Diabetes Mellitus; von Herrath, MG, Ed. Karger Press, New York (2001), p31-67
3. Patterson CC, Dahlquist G, Soltesz G, Green A: Is childhood-onset type 1 diabetes a wealth related disease? An ecological analysis of European incidence rates. Diabetologia 44 (Suppl. 1): 9-16, 2001.
4. Jameson SC, Bevan MJ: T cell selection. Curr. Opin. Immunol. 10: 214-219, 1998.
5. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS: Selection of the T cell repertoire. Annu. Rev. Immunol. 17: 829-874, 1999.
6. Abbas AK: Die and let live: eliminating dangerous lymphocytes. Cell 84: 655-657, 1996.
7. Jansen A, van Hagen M, Drexhage HA: Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 345: 491-492, 1995.
8. Takahashi K, Honeyman MC, Harrison LC: Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin dependent diabetes. J. Immunol. 161: 2629-2635, 1998.
9. Litherland SA, Xie XT, Hutson AD, Wasserfall C, Whittaker DS, She JX, Hofig A, Dennis MA, Fuller K, Cook R, Schatz D, Moldawer LL, Clare-Salzler MJ: Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J. Clin. Invest. 104: 515-523, 1999.
10. Atkinson MA, Leiter EH: The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med. 5: 601-604, 1999.
11. Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L: Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34: 2-5, 1991.
12. Rewers M, Atkinson M: The possible role of enteroviruses in diabetes mellitus. In: Human enterovirus infections.; Rotbart, HA, Ed. Library of Congress, Washington DC (1995), p353-384
13. Ramsingh AI, Chapman N, Tracy S: Coxsakieviruses and diabetes. Bioessays 19: 793-800, 1997.
14. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N: Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Medicine 4: 781-785, 1998.
15. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA: Acceleration of type I diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T cells in pancreatic islets. Diabetes 49: 708-711, 2000.
16. Karoven M, Tuomilehto J, Libman I, LaPorte R: A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 883-892, 1993.
17. Onkama P, Vaananen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type 1 diabetes-the analysis of data on published incidence trends. Diabetologia 42: 1395-1403, 1999.
18. Thorsby E, Undlien D: The HLA associated predisposition to type 1 diabetes and other autoimmune diseases. J. Ped. Endocrin. Metab. 9: 75-88, 1996.
19. van Rood JJ, Claas FHJ, de Vries RRP: HLA, plagues and people. In: The role of micro-organisms in non-infectious diseases; de Vries, RRP, Cohen, IR , and van Rood, JJ, Ed. Springer-Verlag, London (1990), p1-5
20. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T: On the pathogenesis of IDDM. Diabetologia 37 (Suppl 2): 82-89, 1994.
21. Hamilton-Williams EE, Serreze DV, Charlton B, Johnson EA, Marron MP, Mullbacher A, Slattery RM: Transgenic rescue implicates ß2-Microglobulin as a diabetes susceptibility gene in NOD mice. Proc. Natl. Acad. Sci. USA 98: 11533-11538, 2001.
22. Robles DT, Eisenbarth GS, Wang T, Erlich HA, Bugawan TL, Babu SR, Barriga K, Norris J, Hoffman M, Klingensmith G, Yu L, Rewers M: Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin. Immunol. in press: 2002.
23. Marron MP, Graser RT, Chapman HD, Serreze DV: Transgenic analyses in NOD mice provide direct evidence for the mediation of diabetogenic T cell responses by human HLA-A2.1 MHC class I molecules. J. Exp. Med. submitted: 2002.